Joseph Pantginis, an analyst from H.C. Wainwright, reiterated Buy.
https://www.tipranks.com/news/ratings/actinium-pharmaceuticals-promising-clinical-advancements-and-strong-financial-outlook-support-buy-rating
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.